Skip to main content

CAR-T and the Management of 2L LBCL | GileadPro

Watch the recent webinar: View from the UK: CAR T and the Management of 2L LBCL

This interactive webinar discussing case studies and practical management from the UK CAR T experience, with a focus on 2L LBCL and treatment outcomes for patients.

Chair: Professor Simon Harrison, Director, Centre of Excellence for Cellular Immunotherapy and Haematologist at Peter MacCallum Cancer Centre.

Speakers:

Dr Tobias Menne, MD, PhD, MRCP, FRCPath, Consultant haematologist, CAR T-cell Lead and Clinical Director for Research at The Newcastle upon Tyne Hospitals.

Dr Laura Dunning, MBBS (Hons) MRCP, FRCPath, gp Cert Med Ed, Consultant haematologist at James Cooke Hospital, Middlesbrough.